Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib. [electronic resource]

By: Contributor(s): Producer: 20110915Description: 3084-95 p. digitalISSN:
  • 1476-5594
Subject(s): Online resources: In: Oncogene vol. 30
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.